Seroprevalence of anti-Toxoplasma gondii and anti-Borrelia species antibodies in patients with schizophrenia: a case-control study from western Turkey

Basit Öğe Kaydı
dc.authoridAlper Akçalı/0000-0003-0325-886X
dc.contributor.authorCevizci, Sibel
dc.contributor.authorCelik, Merve
dc.contributor.authorAlper Akçalı
dc.contributor.authorOyekcin, Demet Gulec
dc.contributor.authorSahin, Ozlem Ozturk
dc.contributor.authorBakar, Coskun
dc.date.accessioned2025-01-27T21:03:34Z
dc.date.available2025-01-27T21:03:34Z
dc.date.issued2015
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjectives. We examined IgG antibody seroprevalence and risk factors for anti-Toxoplasma gondii and anti-Borrelia sp. in schizophrenic patients. Methods. This case-control study included 30 schizophrenic patients and 60 healthy individuals. Serological analyses were identified by using ELISA technique. Results. In the case group the Toxoplasma seropositivity was 33.3% and Borrelia seropositivity was 13.3%, while in the control group the Toxoplasma positivity was 21.7% and Borrelia seropositivity was 15.0%. There was no significant difference with regard to seroprevalence between the groups (P = 0.232; P = 0.832, respectively). There was statistically significant difference between case and control groups related to hand and kitchen utensil hygiene after dealing with raw meat (P = 0.001). Conclusions. Our data showed the rate of Toxoplasma antibodies was higher in the case group, while the rate of Borrelia antibodies was higher in the control group. In both groups the high rates of seropositivity for Toxoplasma gondii and Borrelia sp. is thought to be due to neglect of personal hygiene. The present study also is the first to examine the association between Borrelia sp. and schizophrenia. Further studies are needed to determine whether there is an association between Borrelia sp. and schizophrenia or not.
dc.identifier.doi10.3109/15622975.2015.1012224
dc.identifier.endpage236
dc.identifier.issn1562-2975
dc.identifier.issn1814-1412
dc.identifier.issue4
dc.identifier.pmid25774563
dc.identifier.scopus2-s2.0-84929621432
dc.identifier.scopusqualityQ1
dc.identifier.startpage230
dc.identifier.urihttps://doi.org/10.3109/15622975.2015.1012224
dc.identifier.urihttps://hdl.handle.net/20.500.12428/27340
dc.identifier.volume16
dc.identifier.wosWOS:000354811400003
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofWorld Journal of Biological Psychiatry
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectToxoplasma gondii
dc.subjectBorrelia species
dc.subjectschizophrenia
dc.subjectpublic health
dc.subjectzoonosis
dc.titleSeroprevalence of anti-Toxoplasma gondii and anti-Borrelia species antibodies in patients with schizophrenia: a case-control study from western Turkey
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu